Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

May 13, 2026

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
April 30, 2026

Immunic to Participate in Investor and Medical Conferences in May
April 28, 2026

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
April 23, 2026

Immunic, Inc. Announces 1-for-10 Reverse Stock Split
April 9, 2026

Immunic to Participate in Scientific and Medical Conferences in April

Show per page